Skip to main content
HR 6575 115th Congress House

Medicare Prescription Drug Savings and Choice Act of 2018

Official title: To amend part D of title XVIII of the Social Security Act to deliver a meaningful benefit and lower prescription drug prices under the Medicare Program.

Introduced: July 26, 2018 Introduced by: Schakowsky, Janice D. Democratic · Illinois See on congress.gov
Health Administrative remediesCongressional oversightDepartment of Health and Human ServicesGovernment studies and investigations
More subjectsShow fewer subjects
Health care coverage and accessMedicarePrescription drugsPublic contracts and procurement
Sign in to write a letter Sign in to watch
This bill died when the 115th Congress ended
It never became law before the 115th Congress (2017–2018) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Aug 13, 2018
Referred to the Subcommittee on Health.
Jul 27, 2018
Referred to the Subcommittee on Health.
Jul 26, 2018
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jul 26, 2018
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action August 13, 2018

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Medicare Prescription Drug Savings and Choice Act of 2018

This bill requires the Centers for Medicare & Medicaid Services (CMS) to offer one or more Medicare-operated prescription drug plan options under the Medicare prescription drug benefit.  In doing so, the CMS must: (1) negotiate prices with drug manufacturers; (2) establish an appeals process for denials of plan benefits, including the option for external review and determination by an independent entity; and (3) establish and apply a formulary and formulary incentives. In general, a Medicare-operated drug plan must meet the same requirements as apply to any other prescription drug plan.

 Related & companion bills 1
  • HR 1775 Related bill Prescription Reduction in Costs for Everyone (PRICE) Act of 2017
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 4
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 6575: Medicare Prescription Drug Savings and Choice Act of 2018. 115th Congress. Open America. https://openamerica.io/bill/115-HR-6575/
MLA
"H.R. 6575: Medicare Prescription Drug Savings and Choice Act of 2018." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-HR-6575/.
Bluebook (legal)
H.R. 6575, 115th Cong. (2026), https://openamerica.io/bill/115-HR-6575/.
Markdown link
[H.R. 6575: Medicare Prescription Drug Savings and Choice Act of 2018](https://openamerica.io/bill/115-HR-6575/)
Report a problem